Get the tools used by (smart)2 investors.
SP500 -2.0%DOW -1.7%FTSE 100 -0.1%NIKKEI -3.1%OIL -0.9%GOLD 0.7%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

Operating Cash Flow Per Share for Cytosorbents Crp

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

CTSO: Cytosorbents Crp

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous...

1.00 USD
Price
– USD
Fair Value
–
Upside
0.70 - 1.61
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Cytosorbents Crp's Operating Cash Flow Per Share:

Dec 2015Dec 2017Dec 2019Dec 2021Dec 2023-0.60-0.40-0.20
Performance Summary
  • Cytosorbents Crp's latest twelve months operating cash flow per share is -0.34
  • Cytosorbents Crp's operating cash flow per share for fiscal years ending December 2019 to 2023 averaged -0.41.
  • Cytosorbents Crp's operated at median operating cash flow per share of -0.41 from fiscal years ending December 2019 to 2023.
  • Looking back at the last 5 years, Cytosorbents Crp's operating cash flow per share peaked in December 2020 at -0.13.
  • Cytosorbents Crp's operating cash flow per share hit its 5-year low in December 2022 of -0.65.
  • Cytosorbents Crp's operating cash flow per share decreased in 2019 (-0.52, +50.9%), 2021 (-0.32, +147.8%), and 2022 (-0.65, +100.9%) and increased in 2020 (-0.13, -74.8%) and 2023 (-0.41, -35.9%).

How does Cytosorbents Crp's Operating Cash Flow Per Share benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Cytosorbents Crp because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Cytosorbents Crp Operating Cash Flow Per Share Benchmarks
NameTickerOperating Cash Flow Per Share
HealthcareSECTOR:HLTH.US-0.48
Sight Sciences IncNASDAQGS:SGHT-0.44
Precision Optics Corporation IncNASDAQCM:POCI-0.36
Cytosorbents CrpNASDAQCM:CTSO-0.34
Paragon 28 IncNYSE:FNA-0.32
Neuroone Medical Technologies CorpNASDAQCM:NMTC-0.23
Vaso CorpOTCPK:VASO0.012
Zynex IncNASDAQGS:ZYXI0.40
Envista Holdings CorpNYSE:NVST1.96
Baxter International IncNYSE:BAX2
Lantheus Holdings IncNASDAQGM:LNTH7.84
Retractable Technologies IncNYSEAM:RVPNA

Metric Usage: Operating Cash Flow Per Share

Hide this widget
ocf_share
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Operating Cash Flow Per Share in the financials category include:

  • Assets of Discontinued Operations, Long-term - The aggregate value of non-current assets from business segments that a company has disposed of or wants to dispose of in the near future.
  • Book Value / Share - The book value of common equity on a per basic share basis.
  • Salaries and Other Emply. Benefits - This item represents the salaries and other benefits provided to the employees.
  • Deferred Domestic Taxes - This item represents the deferred amount of domestic taxes, payable by the company to its home country. For a US Company, taxes deferred to the U.S. government will be deferred domestic taxes. For a non-U.S. company, taxes deferred to its own country's government will be considered as deferred domestic taxes.
View Full List

Search for metric or datapoint

Operating Cash Flow Per Share

Operating cash flow on a per common share basis.

Definition of Operating Cash Flow Per Share

Hide this widget
Operating cash flow on a per common share basis.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-15.62-8.62-1.6211.160200400600800

The chart above depicts the distribution of operating cash flow per share for companies operating in the Healthcare sector in the Developed economic region. Over 2,375 companies were considered in this analysis, and 2,284 had meaningful values. The average operating cash flow per share of companies in the sector is -0.29 with a standard deviation of 2.65.

Cytosorbents Crp's Operating Cash Flow Per Share of -0.34 ranks in the 33.0% percentile for the sector. The following table provides additional summary stats:

Operating Cash Flow Per Share In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,380
Included Constituents2,284
Min-15.65
Max11.13
Median-0.020
Mean-0.29
Standard Deviation2.65

You can find companies with similar operating cash flow per share using this stock screener.

All rights reserved. Terms Of Use